PATENT CLAIM ANALYSIS

Application Number: 16214455
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["435", "007920"]

Abstract:
The invention relates to an anti-human p53 antibody suitable for specifically binding a linear epitope which is exposed only in a conformationally altered isoform of the characteristic p53 protein of patients with Alzheimer's disease or prone to develop Alzheimer's disease or cognitive impairment during ageing. Methods and diagnostic and prognostic kits are also described.

Claim (Index 19):
The in vitro method according to  claim 15 , wherein the biological sample is blood, plasma, serum, saliva, urine, neuronal cells, blood cells or other cell types.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.20833
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15515693', '15342629', '15599685', '08466554', '13363214']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5253192124457191
- 35 USC 102 Novelty (BERT): 0.5332526985921727
- Combined Prediction Score: 0.5261125610603645
- Mean Citation Score: 228.56466
- Max Citation Score: 340.3119
- Similarity Product: 235.0823729905485

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test